New scan could save time and money for prostate cancer patients
NCT ID NCT06828263
First seen Jan 06, 2026 · Last updated May 08, 2026 · Updated 19 times
Summary
This study looks at whether a type of scan called SPECT/CT can help doctors see if treatment is working in men with advanced prostate cancer. The treatment uses a radioactive drug (Lu-177 PSMA) that targets cancer cells. Researchers want to see if SPECT/CT, which is cheaper and more available than PET scans, can give early clues about how well the treatment is working. About 130 men with metastatic castration-resistant prostate cancer will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER METASTATIC DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Grenoble Alpes
RECRUITINGGrenoble, 38053, France
Conditions
Explore the condition pages connected to this study.